Oncolytics After 2017 Refresh: New CEO Makes New Year Resolutions

 
• By Lucie Ellis-Taitt
2018
Oncolytics prepares to launch Phase III trial in 2018 for lead drug • Source: Shutterstock

More from Strategy

More from Business